rs4151030

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The c.906C>A (NM_000448.3) variant in RAG1 is a missense variant predicted to cause substitution of Aspartic Acid by Glutamic Acid at amino acid 302 (p.Asp302Glu).The filtering allele frequency (the lower threshold of the 95% CI of 1968/24958) of the c.906C>A variant in RAG1 is 0.07684 for African/African American chromosomes by gnomAD v2.1.1, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1, and therefore meets this criterion (BA1).In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, BA1, as specified by the ClinGen SCID VCEP (VCEP specifications version 1). LINK:https://erepo.genome.network/evrepo/ui/classification/CA214206/MONDO:0000572/123

Frequency

Genomes: 𝑓 0.022 ( 127 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 109 hom. )

Consequence

RAG1
NM_000448.3 missense

Scores

2
7
9

Clinical Significance

Benign reviewed by expert panel B:11

Conservation

PhyloP100: 0.315
Variant links:
Genes affected
RAG1 (HGNC:9831): (recombination activating 1) The protein encoded by this gene is involved in activation of immunoglobulin V-D-J recombination. The encoded protein is involved in recognition of the DNA substrate, but stable binding and cleavage activity also requires RAG2. Defects in this gene can be the cause of several diseases. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BA1

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RAG1NM_000448.3 linkuse as main transcriptc.906C>A p.Asp302Glu missense_variant 2/2 ENST00000299440.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RAG1ENST00000299440.6 linkuse as main transcriptc.906C>A p.Asp302Glu missense_variant 2/21 NM_000448.3 P1P15918-1

Frequencies

GnomAD3 genomes
AF:
0.0221
AC:
3357
AN:
152142
Hom.:
127
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0763
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00955
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.0129
GnomAD3 exomes
AF:
0.00617
AC:
1551
AN:
251246
Hom.:
50
AF XY:
0.00449
AC XY:
609
AN XY:
135778
show subpopulations
Gnomad AFR exome
AF:
0.0805
Gnomad AMR exome
AF:
0.00451
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000467
Gnomad OTH exome
AF:
0.00506
GnomAD4 exome
AF:
0.00241
AC:
3528
AN:
1461886
Hom.:
109
Cov.:
36
AF XY:
0.00207
AC XY:
1506
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0813
Gnomad4 AMR exome
AF:
0.00508
Gnomad4 ASJ exome
AF:
0.000230
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000927
Gnomad4 FIN exome
AF:
0.0000936
Gnomad4 NFE exome
AF:
0.000224
Gnomad4 OTH exome
AF:
0.00462
GnomAD4 genome
AF:
0.0221
AC:
3362
AN:
152262
Hom.:
127
Cov.:
33
AF XY:
0.0209
AC XY:
1558
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0762
Gnomad4 AMR
AF:
0.00954
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000294
Gnomad4 OTH
AF:
0.0128
Alfa
AF:
0.00999
Hom.:
39
Bravo
AF:
0.0249
ESP6500AA
AF:
0.0752
AC:
331
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00743
AC:
902
EpiCase
AF:
0.000818
EpiControl
AF:
0.000652

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 22, 2023- -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 17, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 18, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Recombinase activating gene 1 deficiency Benign:1
Benign, reviewed by expert panelcurationClinGen Severe Combined Immunodeficiency Variant Curation Expert Panel, ClinGenNov 14, 2023The c.906C>A (NM_000448.3) variant in RAG1 is a missense variant predicted to cause substitution of Aspartic Acid by Glutamic Acid at amino acid 302 (p.Asp302Glu). The filtering allele frequency (the lower threshold of the 95% CI of 1968/24958) of the c.906C>A variant in RAG1 is 0.07684 for African/African American chromosomes by gnomAD v2.1.1, which is higher than the ClinGen SCID VCEP threshold (>0.00872) for BA1, and therefore meets this criterion (BA1). In summary, this variant meets the criteria to be classified as Benign for autosomal recessive SCID based on the ACMG/AMP criteria applied, BA1, as specified by the ClinGen SCID VCEP (VCEP specifications version 1). -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C1835931:Combined immunodeficiency due to partial RAG1 deficiency;C2673536:Combined immunodeficiency with skin granulomas;C2700553:Histiocytic medullary reticulosis Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 26, 2022- -
Severe combined immunodeficiency disease Benign:1
Benign, no assertion criteria providedclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJun 04, 2015- -
Histiocytic medullary reticulosis Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive;C2673536:Combined immunodeficiency with skin granulomas Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.67
D
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.23
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.93
D
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
1.1
L
MutationTaster
Benign
1.0
D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-2.0
N
REVEL
Uncertain
0.48
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.030
D
Polyphen
0.98
D
Vest4
0.82
MutPred
0.33
Loss of catalytic residue at N307 (P = 0.2985);
MVP
0.90
MPC
0.68
ClinPred
0.046
T
GERP RS
-0.65
Varity_R
0.64
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4151030; hg19: chr11-36595760; API